Medibase
EN VI JA

VSS data · Tender results

Search VSS drug tender-winning results

Source: quanlythuoc.vss.gov.vn Last synced: 2026-11-12 Latest batch: 2026-11-11 Tender records: 315397

315397 records found. Showing 110301–110350. Unit / total prices in VND.

Drug / ingredient Reg № Unit Unit price Batch
Solu-Medrol
Methyl prednisolon
Strength / route
40mg · Injection
Qty
200 Vial
Total
8,374,200
Group
N1
Manufacturer
Pfizer Manufacturing Belgium NV (Bỉ)
Province / Facility
Ho Chi Minh City · 79053
VN-20330-17 Vial 41,871 2026-03-06
Solu-Medrol
Methyl prednisolon
Strength / route
500mg · Injection
Qty
200 Vial
Total
41,515,800
Group
N1
Manufacturer
Pfizer Manufacturing Belgium NV (Bỉ)
Province / Facility
Hanoi · 01918
540110032623 Vial 207,579 2026-03-06
Solu-Medrol
Methyl prednisolon
Strength / route
40mg · Injection
Qty
700 Vial
Total
29,309,700
Group
N1
Manufacturer
Pfizer Manufacturing Belgium NV (Bỉ)
Province / Facility
Hanoi · 01918
VN-20330-17 Vial 41,871 2026-03-06
Sorafenib Tablets 200 mg
Sorafenib
Strength / route
200mg · Oral
Qty
0 Tablet
Total
0
Group
N2
Manufacturer
Hetero Labs Limited (India)
Province / Facility
Hanoi · 01916
890114192000 Tablet 234,900 2026-03-06
Sorafenib Tablets 200 mg
Sorafenib
Strength / route
200mg · Oral
Qty
5,000 Tablet
Total
1,174,500,000
Group
N2
Manufacturer
Hetero Labs Limited (India)
Province / Facility
Hanoi · 01916
890114192000 Tablet 234,900 2026-03-06
Spasmomen
Otilonium bromide
Strength / route
40mg · Oral
Qty
12,000 Tablet
Total
42,420,000
Group
N1
Manufacturer
Berlin Chemie AG (Packaging and batch release site: Berlin Chemie AG) (Germany)
Province / Facility
Ho Chi Minh City · 79037
VN-18977-15 Tablet 3,535 2026-03-06
Spasmomen
Otilonium bromide
Strength / route
40mg · Oral
Qty
66,000 Tablet
Total
233,310,000
Group
N1
Manufacturer
Berlin Chemie AG (Packaging and batch release site: Berlin Chemie AG) (Germany)
Province / Facility
Ho Chi Minh City · 79021
VN-18977-15 Tablet 3,535 2026-03-06
Spasmomen
Otilonium bromide
Strength / route
40mg · Oral
Qty
6,000 Tablet
Total
21,210,000
Group
N1
Manufacturer
Berlin Chemie AG (Packaging and batch release site: Berlin Chemie AG) (Germany)
Province / Facility
Ho Chi Minh City · 79053
VN-18977-15 Tablet 3,535 2026-03-06
Spiriva Respimat
Tiotropium
Strength / route
0.0025mg/nhat xit · Inhalation
Qty
1,800 Box
Total
1,440,180,000
Group
N1
Manufacturer
Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
Province / Facility
Ho Chi Minh City · 79037
VN-16963-13 Box 800,100 2026-03-06
Spreabac 2g
Cefoperazon + sulbactam*
Strength / route
1 g, 1g · Injection
Qty
25,000 Vial
Total
1,250,000,000
Group
N4
Manufacturer
Am Vi Pharmaceutical JSC (Vietnam)
Province / Facility
Thanh Hoa · 38180
893110589724 Vial 50,000 2026-03-06
Strongfil-20
Afatinib dimaleate
Strength / route
20mg · Oral
Qty
600 Tablet
Total
234,000,000
Group
N4
Manufacturer
Dat Vi Phu Pharmaceutical JSC (Davipharm) (Vietnam)
Province / Facility
Hanoi · 01916
893110296125 Tablet 390,000 2026-03-06
Strongfil-30
Afatinib dimaleate
Strength / route
30mg · Oral
Qty
2,000 Tablet
Total
780,000,000
Group
N4
Manufacturer
Dat Vi Phu Pharmaceutical JSC (Davipharm) (Vietnam)
Province / Facility
Hanoi · 01916
893110296225 Tablet 390,000 2026-03-06
Sugammasyn 100mg/ml
Sugammadex
Strength / route
100mg/ml; 2ml · Injection
Qty
20 Vial
Total
16,500,000
Group
N1
Manufacturer
Manufacturing site: Lyocontract GmbH; Packaging site: Biosyn Arzneimittel GmbH; Batch release site: Biosyn Arzneimittel GmbH (Germany)
Province / Facility
Ho Chi Minh City · 79831
400110328225 Vial 825,000 2026-03-06
Sulraapix 1,5g
Cefoperazon + sulbactam*
Strength / route
1g+0,5g · Injection
Qty
30,000 Ampoule/Vial
Total
2,253,600,000
Group
N2
Manufacturer
Pymepharco JSC (Vietnam)
Province / Facility
Thanh Hoa · 38180
VD-35470-21 Ampoule/Vial 75,120 2026-03-06
Sumtavis
Famotidin
Strength / route
40mg · Oral
Qty
3,000 Sachet
Total
10,050,000
Group
N4
Manufacturer
Ha Tay Pharmaceutical JSC (Vietnam)
Province / Facility
Quang Binh · 44001
VD-33448-19 Sachet 3,350 2026-03-06
Sumtavis
Famotidin
Strength / route
40mg · Oral
Qty
0 Sachet
Total
0
Group
N4
Manufacturer
Ha Tay Pharmaceutical JSC (Vietnam)
Province / Facility
Quang Binh · 44001
893110885024 Sachet 3,350 2026-03-06
Suopinchon Injection
Furosemid
Strength / route
20mg, dung tich 2ml · Injection
Qty
0 Ampoule
Total
0
Group
N2
Manufacturer
Siu Guan Chem Ind Co., Ltd. (Taiwan)
Province / Facility
Tien Giang
471110356625 Ampoule 4,200 2026-03-06
Survanta
Surfactant (Phospholipid chiet xuat tu phoi bo)
Strength / route
25 mg/ml · Endotracheopulmonary
Qty
24 Vial
Total
211,252,800
Group
N1
Manufacturer
AbbVie Inc. (United States)
Province / Facility
Ho Chi Minh City · 79037
QLSP-940-16 Vial 8,802,200 2026-03-06
Symbicort Rapihaler
Budesonid + formoterol
Strength / route
(160mcg; 4.5mcg)/1 dose; 120 dose · Inhalation
Qty
3,600 Canister
Total
1,562,400,000
Group
N1
Manufacturer
AstraZeneca Dunkerque Production (France)
Province / Facility
Ho Chi Minh City · 79037
300110006424 Canister 434,000 2026-03-06
Symbicort Rapihaler
Budesonid + formoterol
Strength / route
160mcg + 4.5mcg (x120 dose) · Inhalation
Qty
750 Canister
Total
325,500,000
Group
N1
Manufacturer
AstraZeneca Dunkerque Production (France)
Province / Facility
Ho Chi Minh City · 79021
300110006424 Canister 434,000 2026-03-06
Symbicort Rapihaler
Budesonid + formoterol
Strength / route
160mcg + 4.5mcg (x120 dose) · Inhalation
Qty
50 Canister
Total
21,700,000
Group
N1
Manufacturer
AstraZeneca Dunkerque Production (France)
Province / Facility
Ho Chi Minh City · 79053
300110006424 Canister 434,000 2026-03-06
Symbicort Turbuhaler
Budesonid + formoterol
Strength / route
(160mcg; 4.5mcg)/1 dose; 60 dose · Inhalation
Qty
3,600 Ampoule
Total
788,400,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Ho Chi Minh City · 79037
VN-20379-17 Ampoule 219,000 2026-03-06
Symbicort Turbuhaler
Budesonid + formoterol
Strength / route
160mcg + 4.5mcg (x60 dose) · Inhalation
Qty
2,400 Ampoule
Total
525,600,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Ho Chi Minh City · 79021
VN-20379-17 Ampoule 219,000 2026-03-06
Symbicort Turbuhaler
Budesonid + formoterol
Strength / route
160mcg + 4.5mcg (x60 dose) · Inhalation
Qty
300 Ampoule
Total
65,700,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Ho Chi Minh City · 79053
VN-20379-17 Ampoule 219,000 2026-03-06
Symbicort Turbuhaler
Budesonid + formoterol
Strength / route
each dose phong thich contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 60 dose · Inhalation
Qty
55 Ampoule
Total
12,045,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Thanh Hoa · 38180
VN-20379-17 Ampoule 219,000 2026-03-06
Symbicort Turbuhaler
Budesonid + Formoterol fumarate dihydrate
Strength / route
each dose phong thich contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 60 dose · Inhalation
Qty
600 Ampoule
Total
131,400,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Thanh Hoa · 38120
VN-20379-17 Ampoule 219,000 2026-03-06
Symbicort Turbuhaler
Budesonid + Formoterol fumarate dihydrate
Strength / route
each dose phong thich contains: Budesonid 160mcg; Formoterol fumarate dihydrate 4.5mcg; 60 dose · Inhalation
Qty
600 Ampoule
Total
131,400,000
Group
N1
Manufacturer
AstraZeneca AB (Sweden)
Province / Facility
Thanh Hoa · 38813
VN-20379-17 Ampoule 219,000 2026-03-06
Syntarpen
Cloxacilin
Strength / route
1g · Injection
Qty
5,000 Ampoule/Vial
Total
315,000,000
Group
N1
Manufacturer
Tarchomin Pharmaceutical Works "Polfa" S.A (Ba Lan)
Province / Facility
Thanh Hoa · 38180
590110006824 Ampoule/Vial 63,000 2026-03-06
Systane Ultra
Polyethylen glycol + Propylen glycol
Strength / route
0,4% + 0,3% · Ophthalmic
Qty
35 Vial
Total
2,103,465
Group
N1
Manufacturer
Alcon Research, LLC (United States)
Province / Facility
Ho Chi Minh City · 79831
VN-19762-16 Vial 60,099 2026-03-06
TELDY
Tenoforvir + lamivudine + dolutegravir
Strength / route
300mg + 300mg + 50mg · Oral
Qty
350,920 Tablet
Total
1,227,167,240
Group
N5
Manufacturer
Hetero Labs Limited (India)
Province / Facility
Da Nang · 48004
890110445523 Tablet 3,497 2026-03-06
TELDY
Dolutegravir (equivalent to Dolutegravir sodium 52.6mg) 50mg; Lamivudine 300mg; Tenofovir disoproxil fumarate (equivalent to Tenofovir disoproxil 245mg) 300mg
Strength / route
50mg,300mg,300mg · Oral
Qty
45,210 Tablet
Total
152,312,490
Group
N5
Manufacturer
Hetero Labs Limited (India)
Province / Facility
Thanh Hoa · 38180
890110445523 Tablet 3,369 2026-03-06
TELDY
Dolutegravir (equivalent to Dolutegravir sodium 52.6mg) 50mg; Lamivudine 300mg; Tenofovir disoproxil fumarate (equivalent to Tenofovir disoproxil 245mg) 300mg
Strength / route
50mg,300mg,300mg · Oral
Qty
50,000 Tablet
Total
179,300,000
Group
N5
Manufacturer
Hetero Labs Limited (India)
Province / Facility
Thanh Hoa · 38120
890110445523 Tablet 3,586 2026-03-06
Taflotan
Tafluprost
Strength / route
0,0375mg/2,5ml · Ophthalmic
Qty
600 Vial
Total
146,879,400
Group
N1
Manufacturer
Manufacturing site: Santen Pharmaceutical Co., Ltd. - Shiga Factory; Secondary packaging and batch release site: Santen Pharmaceutical Co., Ltd. - Noto Factory (Japan)
Province / Facility
Ho Chi Minh City · 79037
VN-20088-16 Vial 244,799 2026-03-06
Tam thất OPC
Tam that
Strength / route
750mg · Oral
Qty
11,180 Tablet
Total
64,799,280
Group
N3
Manufacturer
OPC Pharmaceutical JSC – Binh Duong Branch – OPC Pharmaceutical Factory (Vietnam)
Province / Facility
Ho Chi Minh City · 79831
VD-18325-13 Tablet 5,796 2026-03-06
Tarceva
Erlotinib
Strength / route
150mg (equivalent to 163.93mg Erlotinib hydrochloride) · Oral
Qty
240 Tablet
Total
136,416,720
Group
N1
Manufacturer
CSSX: Delpharm Milano S.r.l; CSXX: F. Hoffmann - La Roche AG (Manufacturing site: Italy; Batch release site: Switzerland)
Province / Facility
Ho Chi Minh City · 79037
VN-17940-14 Tablet 568,403 2026-03-06
Tavanic
Levofloxacin
Strength / route
500mg · Oral
Qty
4,000 Tablet
Total
146,200,000
Group
N1
Manufacturer
Opella Healthcare International SAS (France)
Province / Facility
Ho Chi Minh City · 79021
VN-19455-15 Tablet 36,550 2026-03-06
Tavanic
Levofloxacin
Strength / route
500mg · Oral
Qty
200 Tablet
Total
7,310,000
Group
N1
Manufacturer
Opella Healthcare International SAS (France)
Province / Facility
Hanoi · 01918
VN-19455-15 Tablet 36,550 2026-03-06
Taxotere
Docetaxel
Strength / route
80mg/4ml; 4ml · Injection
Qty
120 Vial
Total
755,863,680
Group
N1
Manufacturer
Sanofi-Aventis Deutschland GmbH (Germany)
Province / Facility
Ho Chi Minh City · 79037
VN-20266-17 Vial 6,298,864 2026-03-06
Taxotere
Docetaxel
Strength / route
20mg/1ml; 1ml · Injection
Qty
120 Vial
Total
222,740,400
Group
N1
Manufacturer
Sanofi-Aventis Deutschland GmbH (Germany)
Province / Facility
Ho Chi Minh City · 79037
VN-20265-17 Vial 1,856,170 2026-03-06
Tazocin
Piperacilin + tazobactam*
Strength / route
4g + 0,5g · Injection
Qty
600 Vial
Total
134,220,000
Group
N1
Manufacturer
Wyeth Lederle S.r.l (Italy)
Province / Facility
Ho Chi Minh City · 79037
800110074023 Vial 223,700 2026-03-06
Tazocin
Piperacilin + tazobactam*
Strength / route
4g, 0.5g · Injection
Qty
2,000 Vial
Total
447,400,000
Group
N1
Manufacturer
Wyeth Lederle S.r.l (Italy)
Province / Facility
Hanoi · 01918
800110074023 Vial 223,700 2026-03-06
Tegretol 200
Carbamazepin
Strength / route
200mg · Oral
Qty
24,000 Tablet
Total
37,296,000
Group
N1
Manufacturer
Novartis Farma S.p.A. (Italy)
Province / Facility
Ho Chi Minh City · 79037
VN-18397-14 Tablet 1,554 2026-03-06
Tegretol CR 200
Carbamazepin
Strength / route
200mg · Oral
Qty
25,200 Tablet
Total
65,620,800
Group
N1
Manufacturer
Novartis Farma S.p.A. (Italy)
Province / Facility
Ho Chi Minh City · 79037
VN-18777-15 Tablet 2,604 2026-03-06
Telmiam
Amlodipin + telmisartan
Strength / route
5mg+40mg · Oral
Qty
54,000 Tablet
Total
376,110,000
Group
N4
Manufacturer
DRP Inter Co., Ltd. (Vietnam)
Province / Facility
Thanh Hoa · 38180
893110238923 Tablet 6,965 2026-03-06
Telsar-H 40/12.5
Telmisartan + hydroclorothiazid
Strength / route
12,5mg; 40mg · Oral
Qty
1,440 Tablet
Total
1,245,600
Group
N2
Manufacturer
Hetero Labs Limited (India)
Province / Facility
Ho Chi Minh City · 79831
890110345825 Tablet 865 2026-03-06
Telyniol night
Paracetamol + diphenhydramin
Strength / route
500mg + 25mg · Oral
Qty
100,000 Tablet
Total
55,000,000
Group
N4
Manufacturer
Thanh Nam Pharmaceutical Manufacturing and Trading Co., Ltd. – Branch (Vietnam)
Province / Facility
Thanh Hoa · 38180
893100258100 Tablet 550 2026-03-06
Tharodas
Dia long, Hoang ky, Duong quy, Xich thuoc, Xuyen khung, Dao nhan, Hong hoa.
Strength / route
1,06g; 0,53g; 0,35g; 0,26g; 0,26g; 0,26g; 0,26g · Oral
Qty
20,280 Sachet
Total
157,028,040
Group
N3
Manufacturer
Thanh Phat Pharmaceutical JSC (Vietnam)
Province / Facility
Ho Chi Minh City · 79831
TCT-00063-22 Sachet 7,743 2026-03-06
Thuốc tiêm Fentanyl citrate
Fentanyl
Strength / route
0,5mg/10ml · Injection
Qty
80 Ampoule
Total
2,240,000
Group
N5
Manufacturer
Yichang Humanwell Pharmaceutical Co., Ltd (China)
Province / Facility
Ho Chi Minh City · 79831
690111337925 Ampoule 28,000 2026-03-06
Thuốc tiêm Fentanyl citrate
Fentanyl
Strength / route
0,5mg/ 10ml · Injection
Qty
10,000 Ampoule
Total
280,000,000
Group
N5
Manufacturer
Yichang Humanwell pharmaceutical Co., Ltd (China)
Province / Facility
Hanoi · 01916
VN-18482-14 Ampoule 28,000 2026-03-06
Thập toàn đại bổ
Duong quy, Bach truat, Nhan sam/Dang sam, Que nhuc, Thuc dia, Cam thao, Hoang ky, Phuc linh/Bach linh, Xuyen khung, Bach thuoc.
Strength / route
(454,0mg; 302,5mg; 302,5mg; 75,5mg; 454,0mg; 151,5mg; 302,5mg; 302,5mg; 151,5mg; 302,5mg)/4,5g. · Oral
Qty
24,000 Tablet
Total
57,960,000
Group
N3
Manufacturer
OPC Pharmaceutical JSC – Binh Duong Branch – OPC Pharmaceutical Factory (Vietnam)
Province / Facility
Ho Chi Minh City · 79831
VD-22494-15 Tablet 2,415 2026-03-06

Reference data only. Verify directly against the VSS portal before relying on it for tender or commercial decisions.

Services by MTC

Need regulatory support in Vietnam?

Handled by MTC Consulting & Trading Co., Ltd, the team behind Medibase — medibase@mtcorp.vn

About this data

Drug tender results published by Vietnam Social Security (VSS) at quanlythuoc.vss.gov.vn/kqdt. Medibase mirrors and indexes it. Each record is one drug line-item at one healthcare facility in one publication batch. Scope: from 2024 onward.